Driving change to defeat serious chronic diseases, built upon our heritage in diabetes.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 63,400 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com.
This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam.
Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in:
https://www.novonordisk.com/contact-us/find-local-information.html
For other customer complaints, please contact us here:
https://www.novonordisk.com/contact-us.html
Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed.
Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users.
Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Pharmaceuticals, Insulin, obesity, Rare Diseases, and Diabetes
Novo Nordisk | driving change to defeat serious chronic diseases
Entity | Type | Tweets | Articles | |
---|---|---|---|---|
Women in Data Science (WiDS) Worldwide Higher Education, IT Services | Other 18 Apr 2022 | | ||
Salud35 Newspaper Publishing | Other 28 Apr 2023 | | ||
Temerty Faculty of Medicine, University of Toronto Higher Education, deeptech, healthtech | Other 5 Mar 2024 | | ||
Acuam® HealthCare - PHARMA MARKETING DOERS healthtech, martech, Business Consulting and Services | Other 30 Apr 2022 | | ||
International Diabetes Federation healthtech, Non-profit Organizations | Other 3 Dec 2015 | | ||
Ashemadrid - Asociación de Hemofilia de la Comunidad de Madrid healthtech, Wellness and Fitness Services | Other 30 Jun 2023 | | ||
Federación Española de Hemofilia healthtech, Wellness and Fitness Services | Other 18 Oct 2023 | | ||
Federación Española de Diabetes (FEDE) healthtech, Non-profit Organizations | Other 30 Jun 2023 | | ||
MSB (Swedish Civil Contingencies Agency) Government Administration | Other 11 May 2021 | | ||
Verband Forschender Arzneimittelhersteller e.V. (VFA) civictech, Pharmaceutical Manufacturing | Other 30 Mar 2024 | |